Crewe Advisors’s Organon & Co OGN Stock Holding History

Crewe Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$163	Hold	12	–	–	﹤0.01%	1104
2026 Q1	$72	Hold	12	–	–	﹤0.01%	1021
2025 Q4	$87	Hold	12	–	–	﹤0.01%	1077
2025 Q3	$129	Hold	12	–	–	﹤0.01%	946
2025 Q2	$117	Hold	12	–	–	﹤0.01%	728
2025 Q1	$179	Hold	12	–	–	﹤0.01%	698
2024 Q4	$180	Hold	12	–	–	﹤0.01%	632
2024 Q3	$230	Sell	12 -18	-60%	-$373	﹤0.01%	690
2024 Q2	$621	Hold	30	–	–	﹤0.01%	907
2024 Q1	$564	Sell	30 -81	-73%	-$1.39K	﹤0.01%	904
2023 Q4	$1.6K	Hold	111	–	–	﹤0.01%	301
2023 Q3	$1.93K	Hold	111	–	–	﹤0.01%	333
2023 Q2	$2.31K	Sell	111 -258	-70%	-$5.61K	﹤0.01%	527
2023 Q1	$8.68K	Hold	369	–	–	﹤0.01%	576
2022 Q4	$10.3K	Buy	369 +77	+26%	+$1.97K	﹤0.01%	544
2022 Q3	$7K	Buy	292 +3	+1%	+$91	﹤0.01%	769
2022 Q2	$10K	Buy	289 +259	+863%	+$9.07K	﹤0.01%	601
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	463
2021 Q4	$1K	Buy	30 +18	+150%	+$586	﹤0.01%	390
2021 Q3	$0	Hold	12	–	–	﹤0.01%	445
2021 Q2	$0	Buy	+12	New	+$395	﹤0.01%	475

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Crewe Advisors's OGN Position: Q2 2026 in Review

Crewe Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 12 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Crewe Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $10.3K in Q4 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Crewe Advisors held 12 shares of Organon & Co worth $163 as of Q2 2026.
Crewe Advisors left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #1104 holding.
Crewe Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
Crewe Advisors's Organon & Co position peaked at $10.3K in Q4 2022.
631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.